Daniel Galbraith

935 total citations
19 papers, 725 citations indexed

About

Daniel Galbraith is a scholar working on Genetics, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniel Galbraith has authored 19 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniel Galbraith's work include Viral Infections and Immunology Research (5 papers), Xenotransplantation and immune response (5 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). Daniel Galbraith is often cited by papers focused on Viral Infections and Immunology Research (5 papers), Xenotransplantation and immune response (5 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). Daniel Galbraith collaborates with scholars based in United Kingdom, United States and India. Daniel Galbraith's co-authors include G. B. Clements, K. W. Taylor, Alexander W. Tucker, David Onions, Paul McEwan, J.A. Black, Kenneth T. Smith, Ashley Shepherd, Ann L. Griffen and Irene A. Doherty and has published in prestigious journals such as The Lancet, Transplantation and Journal of General Virology.

In The Last Decade

Daniel Galbraith

19 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Galbraith United Kingdom 14 398 265 195 160 112 19 725
Amir‐Babak Sioofy‐Khojine Finland 17 392 1.0× 175 0.7× 289 1.5× 310 1.9× 134 1.2× 36 831
Tanja Ruokoranta Finland 9 283 0.7× 127 0.5× 126 0.6× 154 1.0× 64 0.6× 16 472
Gun Frisk Sweden 26 1.2k 3.0× 586 2.2× 576 3.0× 498 3.1× 472 4.2× 59 1.7k
Isis Ricaño-Ponce Netherlands 14 291 0.7× 168 0.6× 18 0.1× 79 0.5× 335 3.0× 25 812
Katarzyna Sitnik Sweden 14 61 0.2× 100 0.4× 41 0.2× 70 0.4× 604 5.4× 22 938
Margaret Haire United Kingdom 16 52 0.1× 26 0.1× 88 0.5× 118 0.7× 167 1.5× 47 714
B.R. Jones New Zealand 14 88 0.2× 231 0.9× 72 0.4× 53 0.3× 13 0.1× 33 622
JillM. Forrest Australia 6 305 0.8× 166 0.6× 23 0.1× 65 0.4× 102 0.9× 8 469
M. Baldi Italy 13 114 0.3× 86 0.3× 23 0.1× 79 0.5× 70 0.6× 39 940
Lise Nikolic Nielsen Denmark 15 80 0.2× 53 0.2× 22 0.1× 34 0.2× 54 0.5× 56 623

Countries citing papers authored by Daniel Galbraith

Since Specialization
Citations

This map shows the geographic impact of Daniel Galbraith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Galbraith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Galbraith more than expected).

Fields of papers citing papers by Daniel Galbraith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Galbraith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Galbraith. The network helps show where Daniel Galbraith may publish in the future.

Co-authorship network of co-authors of Daniel Galbraith

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Galbraith. A scholar is included among the top collaborators of Daniel Galbraith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Galbraith. Daniel Galbraith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Galbraith, Daniel, et al.. (2021). What makes a good antibody–drug conjugate?. Expert Opinion on Biological Therapy. 21(7). 841–847. 41 indexed citations
2.
Gazda, Lawrence S., James E. Collins, Robert W. Holdcraft, et al.. (2016). A comprehensive microbiological safety approach for agarose encapsulated porcine islets intended for clinical trials. Xenotransplantation. 23(6). 444–463. 43 indexed citations
3.
4.
Galbraith, Daniel. (2004). Regulatory and microbiological safety issues surrounding cell and tissue‐engineering products. Biotechnology and Applied Biochemistry. 40(1). 35–39. 5 indexed citations
5.
Galbraith, Daniel, et al.. (2003). Detection of infectious Bovine polyomavirus. Biologicals. 31(4). 303–306. 8 indexed citations
6.
Tucker, Alexander W., F. McNeilly, Brian Meehan, et al.. (2003). Methods for the exclusion of circoviruses and gammaherpesviruses from pigs. Xenotransplantation. 10(4). 343–348. 34 indexed citations
7.
Galbraith, Daniel. (2002). Transmissible spongiform encephalopathies and tissue cell culture. Cytotechnology. 39(2). 117–124. 5 indexed citations
8.
Galbraith, Daniel. (2002). Regulatory Aspects of Recombinant Protein Products by Baculovirus Expression Systems. BioProcessing Journal. 1(2). 47–51. 3 indexed citations
9.
Langford, Gillian, et al.. (2001). IN VIVO ANALYSIS OF PORCINE ENDOGENOUS RETROVIRUS EXPRESSION IN TRANSGENIC PIGS. Transplantation. 72(12). 1996–2000. 24 indexed citations
10.
Galbraith, Daniel, et al.. (2000). Design and validation of immunological tests for the detection of Porcine endogenous retrovirus in biological materials. Journal of Virological Methods. 90(2). 115–124. 15 indexed citations
11.
Black, J.A., Daniel Galbraith, Irene A. Doherty, et al.. (1999). High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. Journal of Virological Methods. 82(2). 185–200. 58 indexed citations
12.
Galbraith, Daniel, et al.. (1999). Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabetic Medicine. 16(6). 509–513. 96 indexed citations
13.
Tucker, Alexander W., Daniel Galbraith, Paul McEwan, & David Onions. (1999). Evaluation of porcine cytomegalovirus as a potential zoonotic agent in xenotransplantation. Transplantation Proceedings. 31(1-2). 915–915. 45 indexed citations
14.
Galbraith, Daniel, et al.. (1997). Evidence for enteroviral persistence in humans.. Journal of General Virology. 78(2). 307–312. 29 indexed citations
15.
Riding, Miriam H., et al.. (1996). Enteroviral polymerase chain reaction in the investigation of aseptic meningitis. Journal of Medical Virology. 50(2). 204–206. 17 indexed citations
16.
Galbraith, Daniel, et al.. (1995). Phylogenetic analysis of short enteroviral sequences from patients with chronic fatigue syndrome. Journal of General Virology. 76(7). 1701–1707. 23 indexed citations
17.
Clements, G. B., Daniel Galbraith, & K. W. Taylor. (1995). Coxsackie B virus infection and onset of childhood diabetes. The Lancet. 346(8969). 221–223. 212 indexed citations
18.
Clements, G. B., et al.. (1995). Detection of enterovirus‐specific RNA in serum: The relationship to chronic fatigue. Journal of Medical Virology. 45(2). 156–161. 47 indexed citations
19.
Galbraith, Daniel, et al.. (1995). Comparison of Coxsackie B neutralization and enteroviral PCR in chronic fatigue patients. Journal of Medical Virology. 46(4). 310–313. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amir‐Babak Sioofy‐Khojine Breakdown of academic impact, for papers by Tanja Ruokoranta Breakdown of academic impact, for papers by Gun Frisk Breakdown of academic impact, for papers by Isis Ricaño-Ponce Breakdown of academic impact, for papers by Katarzyna Sitnik Breakdown of academic impact, for papers by Margaret Haire Breakdown of academic impact, for papers by B.R. Jones Breakdown of academic impact, for papers by JillM. Forrest Breakdown of academic impact, for papers by M. Baldi Breakdown of academic impact, for papers by Lise Nikolic Nielsen
Rankless by CCL
2026